Cocrystal Pharma, Inc. Class Action Lawsuit - COCP

Company
Cocrystal Pharma, Inc. (NASDAQCM: COCP)
Lead Plaintiff Deadline
November 19, 2018 (Expired)
Class Period
September 23, 2013 - September 7, 2018

Expired

Lead Plaintiff Deadline

Nov 19, 2018

Never Miss Another Deadline

Choose your preferred way to stay informed of new case launches and settlement deadlines

WhatsApp

Scan the QR code or click the button to join

Join on WhatsApp

Get Updates by Email

Required Field

Required Field

Required Field

No Spam, opt-out anytime, alert list is free

Allegations

(1) defendants were engaged in a pump-and-dump scheme to artificially inflate Cocrystal’s stock price; (2) this illicit scheme would result in governmental scrutiny, including from the SEC; (3) defendants failed to abide by SEC disclosure regulations; and (4) as a result, defendants’ statements about Cocrystal’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Eligibility

In order to be eligible to join the COCP class action lawsuit, you must have incurred a loss on shares of purchased during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in during the relevant time frame or pursuant to the relevant offering(s), you have until November 19, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Cocrystal Pharma, Inc. Class Action Lawsuit Details

Levi & Korsinsky announces a class action on behalf of Cocrystal Pharma, Inc. (NASDAQCM: COCP) (f/k/a BioZone Pharmaceuticals, Inc.) shareholders who purchased shares between September 23, 2013 and September 7, 2018. If you suffered a loss in Cocrystal you have until November 19, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

TOP